Skip to main content
SpringerLink
Log in

A recent report to the German government is being hailed as a significant revision to drug policy.

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. United BioSource Corporation.United BioSource Scientist Leads Development of New Guidelines for Drug Reimbursement by German Government. Media Release: 19 Feb 2008. Available from: URL: http://www.unitedbiosource.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

A recent report to the German government is being hailed as a significant revision to drug policy.. Pharmacoecon. Outcomes News 548, 10 (2008). https://doi.org/10.2165/00151234-200805480-00034

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805480-00034

Keywords

Search

Navigation